CASEIN KINASE 1delta (CK 1delta) INHIBITORS AND THEIR USE IN THE TREATMENT OF NEURODE-GENERATIVE DISEASES SUCH AS TAUOPATHIES
申请人:Sheridan Joseph M.
公开号:US20140031547A1
公开(公告)日:2014-01-30
The invention relates to pharmaceutical compositions comprising casein kinase 1 delta (CK1δ) and to the use of said inhibitors in the treatment of neurodegenerative disorders such as Alzheimer's disease.
CASEIN KINASE 1delta (CK 1delta) INHIBITORS AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES SUCH AS TAUOPATHIES
申请人:Electrophoretics Limited
公开号:US20160354375A1
公开(公告)日:2016-12-08
The invention relates to pharmaceutical compositions comprising casein kinase 1 delta (CK1δ) and to the use of said inhibitors in the treatment of neurodegenerative disorders such as Alzheimer's disease.
Nucleophilic displacement of primary amino groups via 1-substituted 4-tosylimidazoles
作者:Edward C. Taylor、John L. LaMattina、Chi Ping Tseng
DOI:10.1021/jo00132a013
日期:1982.5
Preparation of 1,5-Disubstituted Tetrazoles Under Phase-Transfer Conditions
作者:T. V. Artamonova、A. B. Zhivich、M. Yu. Dubinskii、G. I. Koldobskii
DOI:10.1055/s-1996-4418
日期:1996.12
Imidoyl chlorides, obtained by common methods from a wide range of aromatic mono- and diamides, are smoothly converted to the corresponding tetrazoles in high yields by treatment with NaN3 under phase-transfer conditions.